Comparing Helius Medical Technologies (OTCMKTS:HSDT) and ENDRA Life Sciences (OTCMKTS:NDRA)

Helius Medical Technologies (OTCMKTS:HSDT) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

Profitability

This table compares Helius Medical Technologies and ENDRA Life Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Helius Medical Technologies N/A N/A N/A
ENDRA Life Sciences N/A -347.34% -242.82%

Institutional & Insider Ownership

16.5% of ENDRA Life Sciences shares are owned by institutional investors. 23.0% of Helius Medical Technologies shares are owned by insiders. Comparatively, 11.4% of ENDRA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings for Helius Medical Technologies and ENDRA Life Sciences, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helius Medical Technologies 0 2 0 0 2.00
ENDRA Life Sciences 0 0 3 0 3.00

Helius Medical Technologies currently has a consensus price target of $12.00, indicating a potential upside of 654.72%. ENDRA Life Sciences has a consensus price target of $6.00, indicating a potential upside of 471.43%. Given Helius Medical Technologies’ higher probable upside, equities analysts clearly believe Helius Medical Technologies is more favorable than ENDRA Life Sciences.

Valuation & Earnings

This table compares Helius Medical Technologies and ENDRA Life Sciences’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Helius Medical Technologies N/A N/A N/A N/A N/A
ENDRA Life Sciences $10,000.00 696.15 -$9.80 million ($2.10) -0.50

Helius Medical Technologies has higher earnings, but lower revenue than ENDRA Life Sciences.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain’s ability to compensate for damage due to trauma or disease. The Company’s PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.